No abstract

No abstract

No abstract

Purpose: Human DNA topoisomerase III alpha (hTOP3a) is involved in DNA repair surveillance and cell-cycle checkpoints possibly through formatting complex with tumor suppressors. However, its role in cancer development remained unsolved.Experimental Design: Coimmunoprecipitation, sucrose gradient, chromatin immunoprecipitation (ChIP), real time PCR, and immunoblotting analyses were performed to determine interactions of hTOP3a with p53. Paired cell lines with different hTOP3a levels were generated via ectopic expression and short hairpin RNA (shRNA)-mediated knockdown approaches. Cellular tumorigenic properties were analyzed using cell counting, colony formation, senescence, soft agar assays, and mouse xenograft models.Results: The hTOP3a isozyme binds to p53 and cofractionizes with p53 in gradients differing from fractions containing hTOP3a and BLM. Knockdown of hTOP3a expression (sh-hTOP3a) caused a higher anchorage-independent growth of nontumorigenic RHEK-1 cells. Similarly, sh-hTOP3a and ectopic expression of hTOP3a in cancer cell lines caused increased and reduced tumorigenic abilities, respectively. Genetic and mutation experiments revealed that functional hTOP3a, p53, and p21 are required for this tumor-suppressive activity. Mechanism-wise, ChIP data revealed that hTOP3a binds to the p53 and p21 promoters and positively regulates their expression. Two proteins affect promoter recruitments of each other and collaborate in p21 expression. Moreover, sh-hTOP3a and sh-p53 in AGS cells caused a similar reduction in senescence and hTOP3a mRNA levels were lower in gastric and renal tumor samples.Conclusion: We concluded that hTOP3a interacts with p53, regulates p53 and p21 expression, and contributes to the p53-mediated tumor suppression.

No abstract